Table 6.
Odds Ratio for the Endpoint of HF Hospitalization or Death, including Galectin 3 and ST2
| Unadjusted Logistical Regression | Adjusted Logistical Regression * | |||
|---|---|---|---|---|
| Biomarker | OR (95% CI) | P value | OR (95% CI) | P value |
| NTproBNP | 4.3 (1.6,11.4) | 0.0033 | 1.1 (0.2,5.1) | 0.90 |
| IL-6 | 2.9 (1.3,6.4) | 0.0277 | 1.1 (0.2,5.3) | 0.86 |
| TNFα | 2.6 (1.2,5.5) | 0.0108 | 0.9 (0.3,2.7) | 0.85 |
| cTnI | 3.9 (1.8,8.7) | 0.0008 | 2.0 (0.7,5.6) | 0.17 |
| VEGF | 2.9(1.3,6.4) | 0.0073 | 1.7 (0.6,4.6) | 0.28 |
| Sgx-ET1 | 4.7(2.1,10.5) | 0.0002 | 2.9 (1.1,7.8) | 0.03 |
| CT-ET1 | 9.0(3.7,21.7) | <.0001 | 4.2 (1.2,14.2) | 0.02 |
| galectin3 | 4.0(1.7,9.0) | 0.0010 | 1.9(0.7,5.4) | 0.24 |
| ST2 | 3.0(1.3,7.1) | 0.0106 | 0.7(0.2,2.3) | 0.58 |
Adjusted for biomarkers, age, and sex